In one paragraphArticle in Vaccines, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
10 authors.
Samuel W RovitoSt. Jude Graduate School of Biomedical Sciences, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.ORCID 0009-0000-3073-8215 Po-Ling ChenDepartment of Host-Microbe Interactions, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.ORCID 0000-0002-7179-6144 Guohua YangDepartment of Host-Microbe Interactions, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.
Haley N WrittDepartment of Host-Microbe Interactions, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.
Ashley N ZallaDepartment of Microbiology, Immunology, and Molecular Genetics, University of Kentucky College of Medicine, Lexington, KY 40536, USA.
Marissa A DonofrioDepartment of Microbiology, Immunology, and Molecular Genetics, University of Kentucky College of Medicine, Lexington, KY 40536, USA.ORCID 0009-0007-6732-2310 Jonathan N FogoDepartment of Microbiology, Immunology, and Biochemistry, University of Tennessee Health Science Center, Memphis, TN 38163, USA.ORCID 0000-0001-7490-9813 Richard J WebbySt. Jude Graduate School of Biomedical Sciences, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.ORCID 0000-0002-4397-7132 James D BrienDepartment of Microbiology, Immunology, and Molecular Genetics, University of Kentucky College of Medicine, Lexington, KY 40536, USA.
Charles J RussellSt. Jude Graduate School of Biomedical Sciences, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.ORCID 0000-0001-5683-3990 Funding
COVID Supplement - COMPONENT A OF THE COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTERS (CIVICS) PROGRAM TO DESIGN AND EVALUATE INNOVATIVE INFLUENZA VACCINE APPROACHES,75N93019C00052 · NIAID · UNIVERSITY OF GEORGIA · PI ROSS, TED · 2019 to 2025
$74.6MNational Institute of Allergy and Infectious DiseasesNIH HHS 75N93019C00052
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
antigen engineeringH1N1hemagglutininimmunogenicityinfluenza vaccinemRNA vaccinestalk antibody
Identifiers
PMID42646718
PMCPMC13517961
What OpenQuestion holds
Textmetadata
Read underepoch 390